Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04524416 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MINIject Global Long-Term Follow-up Study

Study acronym: STAR-GLOBAL
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2025 to Dec 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 300 to confirmed 116
    • Site details revised at 9 of 9 sites
    v6
  2. Re-verified, no change to tracked fieldsv5
  3. Study sites: 1 to 9v4
  4. 2 versions Re-verified since Jul 26, 2021, no change to tracked fieldsv2-v3
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study will assess the long-term (up to 5 years) safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a MINIject glaucoma implant.
Trial Details
NCT Number NCT04524416
Lead Sponsor iSTAR Medical
Conditions
(from sponsor)		 Open Angle Glaucoma, Ocular Hypertension
Related terms Glaucoma, Open-Angle, Ocular Hypertension
Enrollment 116 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov